Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Maria C. Azevedo Coutinho, Nuno Cortez-Dias, Guilhermina Cantinho, Susana Gonçalves, Nelson Cunha, Tiago Rodrigues, Laura Santos, Isabel Conceição, João Agostinho & Fausto J. Pinto. (2023) Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis. Amyloid 0:0, pages 1-10.
Read now
Read now
Meng Jiang, Mengdie Wang, Zhengyu Tao, Yezi Chai, Qiming Liu, Qifan Lu, Qizhen Wu, Xiaoying Ying, Yanan Huang, Ying Nie, Yuqi Tang, Xin Zhang, Yu Liu & Jun Pu. (2023) Biochemical and biophysical properties of an unreported T96R mutation causing transthyretin cardiac amyloidosis. Amyloid 30:2, pages 188-198.
Read now
Read now
Sofia Möckelind, Jan Axelsson, Björn Pilebro, Per Lindqvist, Ole B. Suhr & Torbjörn Sundström. (2020) Quantification of cardiac amyloid with [18F]Flutemetamol in patients with V30M hereditary transthyretin amyloidosis. Amyloid 27:3, pages 191-199.
Read now
Read now
Maria C. Azevedo Coutinho, Nuno Cortez-Dias, Guilhermina Cantinho, Susana Gonçalves, Miguel Nobre Menezes, Tatiana Guimarães, Gustavo Lima da Silva, Ana Rita Francisco, João Agostinho, Laura Santos, Isabel Conceição & Fausto J. Pinto. (2020) The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease. Amyloid 27:3, pages 174-183.
Read now
Read now
Björn Pilebro, Ole B. Suhr, Ulf Näslund, Per Westermark, Per Lindqvist & Torbjörn Sundström. (2016) 99mTc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis. Upsala Journal of Medical Sciences 121:1, pages 17-24.
Read now
Read now
Elisabet Ihse, Claudio Rapezzi, Giampaolo Merlini, Merrill D. Benson, Yukio Ando, Ole B. Suhr, Shu-ichi Ikeda, Francesca Lavatelli, Laura Obici, Candida C. Quarta, Ornella Leone, Hirofumi Jono, Mitsuharu Ueda, Massimiliano Lorenzini, Juris Liepnieks, Toshinori Ohshima, Masayoshi Tasaki, Taro Yamashita & Per Westermark. (2013) Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. Amyloid 20:3, pages 142-150.
Read now
Read now
Teresa Coelho, Mathew S. Maurer & Ole B. Suhr. (2013) THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Current Medical Research and Opinion 29:1, pages 63-76.
Read now
Read now
Ole B Suhr, Sandra Gustavsson, Victoria Heldestad, Rolf Hörnsten, Per Lindqvist, Erik Nordh & Urban Wiklund. (2012) New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center’s experience. Degenerative Neurological and Neuromuscular Disease 2, pages 93-106.
Read now
Read now
S. Okamoto, J. Wixner, B.-G. Ericzon, S. Friman, P. Lindqvist, M. Henein & O. B. Suhr. (2011) Prognostic value of pre-transplant cardiomyopathy in Swedish liver transplanted patients for familial amyloidotic polyneuropathy. Amyloid 18:sup1, pages 171-173.
Read now
Read now
Rolf Hörnsten, Johanna Pennlert, Urban Wiklund, Per Lindqvist, Steen M. Jensen & Ole B. Suhr. (2010) Heart complications in familial transthyretin amyloidosis: impact of age and gender. Amyloid 17:2, pages 63-68.
Read now
Read now
Ole B. Suhr, Oluf Andersen, Thomas Aronsson, Jenni Jonasson, Hannu Kalimo, Christer Lundahl, Hans-Eric Lundgren, Atle Melberg, Johan Nyberg, Malin Olsson, Arne Sandberg & Per Westermark. (2009) Report of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in Sweden. Amyloid 16:4, pages 208-214.
Read now
Read now
Articles from other publishers (38)
Michael A. Smith & Neil G. Feinglass. (2024) Perioperative implications of amyloidosis and amyloid cardiomyopathy: A review for anesthesiologists. Journal of Clinical Anesthesia 92, pages 111271.
Crossref
Crossref
Aristóteles Comte de Alencar Neto, Caio Rebouças Fonseca Cafezeiro, Bruno Vaz Kerges Bueno, Cristiane de Carvalho Singulane & Fabio Fernandes. 2023. Amyloidosis and Fabry Disease. Amyloidosis and Fabry Disease
43
48
.
Marcelo Imbroinise Bittencourt & Adriana Bastos Carvalho. 2023. Amyloidosis and Fabry Disease. Amyloidosis and Fabry Disease
219
225
.
Scott Arno & Jennifer Cowger. (2021) The genetics of cardiac amyloidosis. Heart Failure Reviews 27:5, pages 1485-1492.
Crossref
Crossref
Farhan Bajwa, Ryan O’Connor & Karthikeyan Ananthasubramaniam. (2021) Epidemiology and clinical manifestations of cardiac amyloidosis. Heart Failure Reviews 27:5, pages 1471-1484.
Crossref
Crossref
Rosa Lauppe, Johan Liseth Hansen, Anna Fornwall, Katarina Johansson, Mark H. Rozenbaum, Anne Mette Strand, Merja Väkeväinen, Johanna Kuusisto, Einar Gude, J. Gustav Smith & Finn Gustafsson. (2022) Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries. ESC Heart Failure 9:4, pages 2528-2537.
Crossref
Crossref
Intissar Anan, Ole B. Suhr, Katarzyna Liszewska, Jorge Mejia Baranda, Björn Pilebro, Jonas Wixner & Elisabet Ihse. (2022) Amyloid fibril composition type is consistent over time in patients with Val30Met (p.Val50Met) transthyretin amyloidosis. PLOS ONE 17:3, pages e0266092.
Crossref
Crossref
Márcia Waddington-Cruz, Jonas Wixner, Leslie Amass, Jan Kiszko, Doug Chapman, Yukio Ando, Fabio Adrian Barroso, Marcelo Rugiero, Johan Van Cleemput, Ivaylo Tarnev, Theodoros Kyriakides, Arnt Kristen, Hartmut Schmidt, Felix Darstein, Burkhard Gess, Josep Maria Campistol Plana, Juan Gonzalez Moreno, Jose Gonzalez Costello, Pablo Garcia Pavia, Roberto Fernandéz Torrón, Francisco Munoz Beamud, Violaine Planté-Bordeneuve, David Adams, Olivier Lairez, Claudio Rapezzi, Giampaolo Merlini, Marco Luigetti, Yoshiki Sekijima, Taro Yamashita, Sonoko Misawa, Soon Chai Low, Hans Nienhuis, Teresa Coelho, Isabel Conceição, Rayomand Press, Yesim Parman, Mathew Maurer, Stephen Gottlieb, Annabel Wang, Brian Drachman, Angela Dispenzieri, Sasa Zivkovic & Daniel Lenihan. (2021) Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Neurology and Therapy 10:2, pages 753-766.
Crossref
Crossref
Rosa Elisabeth Lauppe, Johan Liseth Hansen, Christian Gerdesköld, Mark H Rozenbaum, Anne Mette Strand, Merja Vakevainen, Johanna Kuusisto, Einar Gude, Finn Gustafsson & J Gustav Smith. (2021) Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden. Open Heart 8:2, pages e001755.
Crossref
Crossref
Rabah Alreshq & Frederick L. Ruberg. (2021) Clinical approach to genetic testing in amyloid cardiomyopathy: from mechanism to effective therapies. Current Opinion in Cardiology 36:3, pages 309-317.
Crossref
Crossref
Sandra Ihne, Caroline Morbach, Laura Obici, Giovanni Palladini & Stefan Störk. (2019) Amyloidosis in Heart Failure. Current Heart Failure Reports 16:6, pages 285-303.
Crossref
Crossref
Haruki Koike, Yuki Fukami, Ryoji Nishi, Yuichi Kawagashira, Masahiro Iijima, Gen Sobue & Masahisa Katsuno. (2019) Clinicopathological spectrum and recent advances in the treatment of hereditary transthyretin amyloidosis. Neurology and Clinical Neuroscience 7:4, pages 166-173.
Crossref
Crossref
Brett W Sperry & W. H. Wilson Tang. (2017) Amyloid heart disease: genetics translated into disease-modifying therapy. Heart 103:11, pages 812-817.
Crossref
Crossref
O. B. Suhr, E. Lundgren & P. Westermark. (2017) One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition. Journal of Internal Medicine 281:4, pages 337-347.
Crossref
Crossref
Yesim Parman, David Adams, Laura Obici, Lucía Galán, Velina Guergueltcheva, Ole B. Suhr & Teresa Coelho. (2016) Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe. Current Opinion in Neurology 29:Supplement 1, pages S3-S13.
Crossref
Crossref
Morie A. Gertz, Merrill D. Benson, Peter J. Dyck, Martha Grogan, Terresa Coelho, Marcia Cruz, John L. Berk, Violaine Plante-Bordeneuve, Hartmut H.J. Schmidt & Giampaolo Merlini. (2015) Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis. Journal of the American College of Cardiology 66:21, pages 2451-2466.
Crossref
Crossref
Louise‐Laure MarianiPierre Lozeron, Marie Théaudin, Zoia Mincheva, Aissatou Signate, Beatrice Ducot, Vincent Algalarrondo, Christian Denier, Clovis Adam, Guillaume Nicolas, Didier Samuel, Michel S. Slama, Catherine Lacroix, Micheline Misrahi & David Adams. (2015) Genotype–phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France. Annals of Neurology 78:6, pages 901-916.
Crossref
Crossref
Sandra Arvidsson, Björn Pilebro, Per Westermark, Per Lindqvist & Ole B. Suhr. (2015) Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition. PLOS ONE 10:11, pages e0143456.
Crossref
Crossref
Pablo García-Pavía, Francisco Muñoz-Beamud & Carlos Casasnovas. (2015) Recomendaciones para el diagnóstico y tratamiento de la polineuropatía amiloidótica familiar por transtiretina. Medicina Clínica 145:5, pages 211-217.
Crossref
Crossref
Pablo García-Pavía, Francisco Muñoz-Beamud & Carlos Casasnovas. (2015) Recommendations regarding diagnosis and treatment of transthyretin familial amyloid polyneuropathy. Medicina Clínica (English Edition) 145:5, pages 211-217.
Crossref
Crossref
Adam Castaño, Brian M. Drachman, Daniel Judge & Mathew S. Maurer. (2014) Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs. Heart Failure Reviews 20:2, pages 163-178.
Crossref
Crossref
Masayoshi Tasaki,Mitsuharu Ueda, Konen Obayashi, Haruki Koike, Keisuke Kitagawa, Yasuhiro Ogi, Hirofumi Jono, Yu Su, Genki Suenaga, Toshinori Oshima, Yohei Misumi, Mari Yoshida, Taro Yamashita, Gen Sobue & Yukio Ando. (2013) Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: A proteomic approach. International Journal of Cardiology 170:1, pages 69-74.
Crossref
Crossref
C. Rapezzi, C. C. Quarta, L. Obici, F. Perfetto, S. Longhi, F. Salvi, E. Biagini, M. Lorenzini, F. Grigioni, O. Leone, F. Cappelli, G. Palladini, P. Rimessi, A. Ferlini, G. Arpesella, A. D. Pinna, G. Merlini & S. Perlini. (2012) Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. European Heart Journal 34:7, pages 520-528.
Crossref
Crossref
V. Planté-Bordeneuve & P. Kerschen. 2013. Peripheral Nerve Disorders. Peripheral Nerve Disorders
643
658
.
Haruki Koike, Rina Hashimoto, Minoru Tomita, Yuichi Kawagashira, Masahiro Iijima, Tomohiko Nakamura, Hirohisa Watanabe, Hideya Kamei, Tetsuya Kiuchi & Gen Sobue. (2012) Impact of aging on the progression of neuropathy after liver transplantation in transthyretin Val30Met amyloidosis. Muscle & Nerve 46:6, pages 961-964.
Crossref
Crossref
Arnt V. Kristen, Stephanie Lehrke, Sebastian Buss, Derliz Mereles, Henning Steen, Philipp Ehlermann, Stefan Hardt, Evangelos Giannitsis, Rupert Schreiner, Uwe Haberkorn, Philipp A. Schnabel, Reinhold P. Linke, Christoph Röcken, Erich E. Wanker, Thomas J. Dengler, Klaus Altland & Hugo A. Katus. (2012) Green tea halts progression of cardiac transthyretin amyloidosis: an observational report. Clinical Research in Cardiology 101:10, pages 805-813.
Crossref
Crossref
P. Kerschen & V. Planté-Bordeneuve. (2012) Neuropatie amiloidi familiari. EMC - Neurologia 12:1, pages 1-12.
Crossref
Crossref
Violaine Planté-Bordeneuve & Gerard Said. (2011) Familial amyloid polyneuropathy. The Lancet Neurology 10:12, pages 1086-1097.
Crossref
Crossref
Graciela Martinez-Palli & Andrés Cárdenas. (2011) Pre operative cardio pulmonary assessment of the liver transplant candidate. Annals of Hepatology 10:4, pages 421-433.
Crossref
Crossref
. (2011) Abstracts. Amyloid 18:Suppl. 1, pages 6-238.
Crossref
Crossref
Sadahisa Okamoto, Rolf Hörnsten, Konen Obayashi, Priyantha Wijayatunga & Ole B. Suhr. (2011) Continuous development of arrhythmia is observed in swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant). Liver Transplantation 17:2, pages 122-128.
Crossref
Crossref
P. Kerschen & V. Planté-Bordeneuve. (2011) Neuropathies amyloïdes familiales. EMC - Neurologie 8:4, pages 1-12.
Crossref
Crossref
Bárbara Macedo, Joana Magalhães, Ana Rita Batista & Maria João Saraiva. (2010) Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. Pharmacological Research 62:6, pages 514-522.
Crossref
Crossref
Ana-Paula Barreiros, Felix Post, Maria Hoppe-Lotichius, Reinhold P. Linke, Christian F. Vahl, Hans-Joachim Schäfers, Peter R. Galle & Gerd Otto. (2010) Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: A single-center experience. Liver Transplantation 16:3, pages 314-323.
Crossref
Crossref
Sadahisa Okamoto, Jonas Wixner, Konen Obayashi, Yukio Ando, Bo-Göran Ericzon, Styrbjörn Friman, Makoto Uchino & Ole B. Suhr. (2009) Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients' survival. Liver Transplantation 15:10, pages 1229-1235.
Crossref
Crossref
E Ihse, A Ybo, OB Suhr, P Lindqvist, C Backman & P Westermark. (2008) Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. The Journal of Pathology 216:2, pages 253-261.
Crossref
Crossref
O. B. Suhr, I. Anan, C. Backman, A. Karlsson, P. Lindqvist, S. Mörner & A. Waldenström. (2008) Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?. Journal of Internal Medicine 263:3, pages 294-301.
Crossref
Crossref
Sadahisa Okamoto, Taro Yamashita, Yukio Ando, Mitsuharu Ueda, Yohei Misumi, Konen Obayashi, Yoko Horibata & Makoto Uchino. (2008) Evaluation of Myocardial Changes in Familial Amyloid Polyneuropathy after Liver Transplantation. Internal Medicine 47:24, pages 2133-2137.
Crossref
Crossref